Boehringer Ingelheim
June 23, 2026
Theater 2
Type: Company Presentation
Focus Area:
Multiple Therapeutics
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,300 employees serve over 130 markets to build a healthier and more sustainable tomorrow.
Company HQ City:
Ridgefield
Company HQ State:
CT
Company HQ Country:
United States
Year Founded:
1885
Lead Product in Development:
n/a
CEO
Shashank Deshpande
Development Phase of Lead Product
Other/Not Applicable
When you expect your next catalyst update?
n/a
Primary Speaker
.jpg/fit-in/500x9999/filters:no_upscale())
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}